Year archive

Cinclus Pharma Holding AB — 2025 filings

All 31 regulatory filings released by Cinclus Pharma Holding AB (CINPHA) in 2025, sourced directly from the official regulator.

31 Filings

2025 Period

2025 filings (31)

Filing	Released	Lang
Cinclus Pharmas linaprazan glurate har inkluderats på Kinas nationella ersättningslista och lanseras i Kina 2026 Regulatory Filings	2025-12-08	Swedish
Cinclus Pharma’s linaprazan glurate earns China’s National Reimbursement Listing and is set to launch in China in 2026 Regulatory Filings	2025-12-08	English
Cinclus Pharma rekryterar Magnus Christensen som ny CFO Board/Management Information	2025-12-08	Swedish
Cinclus Pharma recruits Magnus Christensen as new CFO Board/Management Information	2025-12-08	English
Notice of Extraordinary General Meeting in Cinclus Pharma Holding AB (publ) AGM Information	2025-12-08	English
Kallelse till extra bolagsstämma i Cinclus Pharma Holding AB (publ) AGM Information	2025-12-08	Swedish
Cinclus Pharmas valberedning föreslår ny representant för bolagets grundare till styrelsen Board/Management Information	2025-12-01	Swedish
Cinclus Pharma’s Nomination Committee proposes new representative for the company’s founders to the Board Board/Management Information	2025-12-01	English
Interim / Quarterly Report 2025 Interim / Quarterly Report 9M 2025	2025-11-25	English
Interim / Quarterly Report 2025 Interim / Quarterly Report 9M 2025	2025-11-20	Swedish
Cinclus Pharma's Nomination Committee for the 2026 Annual General Meeting appointed AGM Information	2025-11-18	English
Cinclus Pharmas Valberedning för årsstämma 2026 utsedd Report Publication Announcement	2025-11-18	Swedish
Cinclus Pharma inleder fas III-studien HEEALING 1 med linaprazan glurate för patienter med erosiv gastroesofageal refluxsjukdom (GERD) Regulatory Filings	2025-08-29	Swedish
Cinclus Pharma to initiate HEEALING 1 Phase III study of linaprazan glurate in patients with Erosive Gastroesophageal Reflux Disease (GERD) Legal Proceedings Report	2025-08-29	English
Interim / Quarterly Report 2025 Interim / Quarterly Report H1 2025	2025-08-20	Swedish
Interim / Quarterly Report 2025 Interim / Quarterly Report H1 2025	2025-08-20	English
Beslut vid årsstämma i Cinclus Pharma Holding AB (publ) den 22 maj 2025 AGM Information	2025-05-22	Swedish
Resolutions at the Annual General Meeting in Cinclus Pharma Holding AB (publ) on 22 May 2025 AGM Information	2025-05-22	English
Cinclus Pharma ingår partnerskap med Zentiva för att kommersialisera linaprazan glurate i Europa Regulatory Filings	2025-05-22	Swedish
Cinclus Pharma Partners with Zentiva to Commercialize Linaprazan Glurate in Europe Regulatory Filings	2025-05-22	English
Interim / Quarterly Report 2025 Interim / Quarterly Report Q1 2025	2025-05-20	Swedish
Interim / Quarterly Report 2025 Interim / Quarterly Report Q1 2025	2025-05-20	English
Annual Report (ESEF) 2024 Annual Report (ESEF) FY 2024	2025-04-30	Swedish
Annual Report (ESEF) 2024 Annual Report (ESEF) FY 2024	2025-04-30	Swedish
Regulatory Filings 2025 Regulatory Filings	2025-04-17	English
Notice of Annual General Meeting in Cinclus Pharma Holding AB (publ) Proxy Solicitation & Information Statement	2025-04-17	English
Kallelse till årsstämma i Cinclus Pharma Holding AB (publ) AGM Information	2025-04-17	Swedish
Interim / Quarterly Report 2024 Interim / Quarterly Report FY 2024	2025-02-20	Swedish
Interim / Quarterly Report 2024 Interim / Quarterly Report FY 2024	2025-02-20	English
Major Shareholding Notification 2025 Major Shareholding Notification	2025-01-03	Swedish
Major Shareholding Notification 2025 Major Shareholding Notification	2025-01-03	Swedish